Download Citation
Article Source:
Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy
Ricotti V,
Spinty S,
Roper H,
Hughes I,
Tejura B,
et al.
(2016)
Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy.
PLOS ONE 11(4): e0152840.
https://doi.org/10.1371/journal.pone.0152840